219 related articles for article (PubMed ID: 30609309)
1. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
[TBL] [Abstract][Full Text] [Related]
2. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis.
Bay K; Hartung S; Ivell R; Schumacher M; Jürgensen D; Jorgensen N; Holm M; Skakkebaek NE; Andersson AM
J Clin Endocrinol Metab; 2005 Jun; 90(6):3410-8. PubMed ID: 15755855
[TBL] [Abstract][Full Text] [Related]
6. [Endocrine profiles and gonadotropin response to Gn-RH of men with testicular cancer].
Watanabe M; Fuji K; Suzuki K; Kitamura T; Okumura D; Kasahara T; Igarashi T; Masuyama T; Hiramori T; Higaki M; Yoshida H
Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):543-50. PubMed ID: 12910930
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function.
Albrethsen J; Johannsen TH; Jørgensen N; Frederiksen H; Sennels HP; Jørgensen HL; Fahrenkrug J; Petersen JH; Linneberg A; Nordkap L; Bang AK; Andersson AM; Juul A
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32211773
[TBL] [Abstract][Full Text] [Related]
8. Plasma insulin-like peptide 3 concentrations are acutely regulated by luteinizing hormone in pubertal Japanese Black beef bulls.
Hannan MA; Fukami Y; Kawate N; Sakase M; Fukushima M; Pathirana IN; Büllesbach EE; Inaba T; Tamada H
Theriogenology; 2015 Dec; 84(9):1530-5. PubMed ID: 26318230
[TBL] [Abstract][Full Text] [Related]
9. Serum Insulin-like Factor 3, Testosterone, and LH in Experimental and Therapeutic Testicular Suppression.
Albrethsen J; Østergren PB; Norup PB; Sønksen J; Fode M; Kistorp C; Nordsborg NB; Solheim SA; Mørkeberg J; Main KM; Juul A
J Clin Endocrinol Metab; 2023 Oct; 108(11):2834-2839. PubMed ID: 37235781
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like Factor 3, Basal and Human Chorionic Gonadotropin-Stimulated Testosterone as Biomarkers to Predict the Effect of Testosterone Replacement in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency.
Medici C; Jørgensen N; Juul A; Albrethsen J; Kreiberg M; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Bandak M
Clin Genitourin Cancer; 2024 Feb; 22(1):e106-e112.e4. PubMed ID: 37673783
[TBL] [Abstract][Full Text] [Related]
11. Luteinizing hormone regulation by sex steroids in men with germinal and Leydig cell tumours.
Reznik Y; Rieu M; Kuhn JM; Mandard JC; Bottet P; Lemonnier D; Bekka S; Mahoudeau J
Clin Endocrinol (Oxf); 1993 May; 38(5):487-93. PubMed ID: 8392454
[TBL] [Abstract][Full Text] [Related]
12. The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancer.
Bandak M; Aksglaede L; Juul A; Rørth M; Daugaard G
Eur J Cancer; 2011 Nov; 47(17):2585-91. PubMed ID: 21704509
[TBL] [Abstract][Full Text] [Related]
13. INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle Network.
Facondo P; Delbarba A; Maffezzoni F; Cappelli C; Ferlin A
Protein Pept Lett; 2020; 27(12):1246-1252. PubMed ID: 32981493
[TBL] [Abstract][Full Text] [Related]
14. Changes in serum insulin-like factor 3 during normal male puberty.
Ferlin A; Garolla A; Rigon F; Rasi Caldogno L; Lenzi A; Foresta C
J Clin Endocrinol Metab; 2006 Sep; 91(9):3426-31. PubMed ID: 16804040
[TBL] [Abstract][Full Text] [Related]
15. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
17. Acute regulation of plasma insulin-like peptide 3 concentrations by luteinizing hormone in male goats.
Hannan MA; Kawate N; Fukami Y; Pathirana IN; Büllesbach EE; Inaba T; Tamada H
Theriogenology; 2016 Aug; 86(3):749-56. PubMed ID: 27056416
[TBL] [Abstract][Full Text] [Related]
18. Leydig cell function in patients with testicular cancer during and after chemotherapy.
Willemse PH; Sleijfer DT; Schraffordt Koops H; Pratt JJ; Sluiter WJ; Doorenbos H
Int J Androl; 1983 Dec; 6(6):497-508. PubMed ID: 6421750
[TBL] [Abstract][Full Text] [Related]
19. Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Eur J Cancer; 2017 Oct; 84():9-17. PubMed ID: 28772110
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like factor 3 quantification by LC-MS/MS in male patients with hypogonadotropic hypogonadism and Klinefelter syndrome.
Johannsen TH; Ljubicic ML; Young J; Trabado S; Petersen JH; Linneberg A; Albrethsen J; Juul A
Endocrine; 2021 Mar; 71(3):578-585. PubMed ID: 33483888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
